Lantus, the new long-acting "peakless" insulin

May 2001

Patients will soon be able to get Lantus, the new long-acting "peakless" insulin.

It was approved last year...but Aventis had to postpone the launch until they had an adequate supply.

Lantus is an insulin analog called insulin glargine. It differs from human insulin by 3 amino acids.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

many patients are getting drug doses that are too high
Diabetes Lantus, the new long-acting "peakless" insulin
Alzheimer Disease new Alzheimer's drug, Reminyl
Ophthalmology glaucoma patients using two new eyedrops called Lumigan (bimatoprost) and Travatan (travoprost)
Ophthalmology patients getting severe migraines after using Xalatan (latanoprost) eyedrops
Respiratory & Allergy LESS frequent use of antibiotics for treating acute exacerbations of COPD
Cardiology severe muscle pain in patients taking both gemfibrozil (Lopid) and Baycol or other statins
Cardiology more unstable angina patients on Plavix and aspirin
Gastroenterology dose of Pepcid needs to be reduced even in patients with MODERATE renal impairment
Gastroenterology Protonix IV (pantoprazole), the first INTRAVENOUS proton pump inhibitor
Pediatrics rickets is making a comeback
Infectious Diseases Valcyte (valganciclovir) tablets, an improved version of oral Cytovene (ganciclovir)
Infectious Diseases TMP/SMX (Bactrim, Septra) for head lice
Hematology & Oncology mistletoe for breast cancer
Hematology & Oncology melatonin might help prevent or treat breast cancer
Shortages Drug shortages are becoming more common